- Open
- 360.00
- High
- 360.00
- Low
- 352.50
- Close
- 355.84
- Change
- +3.00 (0.85%)
- Volume
- 209,504
| 11 Sept 2026 | 07:00:03 | Director/PDMR Shareholding |
| 10 Sept 2026 | 11:30:00 | Holding(s) in Company |
| 9 Sept 2026 | 07:00:05 | Director/PDMR Shareholding |
| 1 Sept 2026 | 07:00:10 | Total Voting Rights |
| 27 Apr 2026 | Annual Financial Report | |
| 25 Apr 2025 | Chesnara Annual Report & Accounts 2024 | |
| 2 May 2024 | Chesnara Annual Report & Accounts 2023 |
Chesnara plc is a European life, pensions, and investment company that specializes in the consolidation of life and pensions policies. It operates through various business units, including Countrywide Assured and Chesnara Life in the UK, Scildon in the Netherlands, and Movestic in Sweden. The company generates revenue by managing life assurance, investment, and pension policies, while also acquiring closed and open-book businesses to enhance its portfolio and deliver value to customers.
| 11 Sept 2026 | 07:00:03 | Director/PDMR Shareholding |
| 10 Sept 2026 | 11:30:00 | Holding(s) in Company |
| 9 Sept 2026 | 07:00:05 | Director/PDMR Shareholding |
| 1 Sept 2026 | 07:00:10 | Total Voting Rights |
| 27 Apr 2026 | Annual Financial Report | |
| 25 Apr 2025 | Chesnara Annual Report & Accounts 2024 | |
| 2 May 2024 | Chesnara Annual Report & Accounts 2023 |
Chesnara plc is a European life, pensions, and investment company that specializes in the consolidation of life and pensions policies. It operates through various business units, including Countrywide Assured and Chesnara Life in the UK, Scildon in the Netherlands, and Movestic in Sweden. The company generates revenue by managing life assurance, investment, and pension policies, while also acquiring closed and open-book businesses to enhance its portfolio and deliver value to customers.
| 26 Aug 2026 |
| 07:00:02 |
| Director/PDMR Shareholding |
| 29 Aug 2026 |
| Chesnara, Solvonis Therapeutics, hVIVO, Gelion, Tertiary Minerals, Iofina - Small Cap Week in Review |
| 28 Aug 2026 | Insider: FTSE 250 directors lock in 7% yield |
| 27 Aug 2026 | RBC lifts Chesnara price target to 400p on stronger cash generation |
| 26 Aug 2026 | Berenberg raises target price on Chesnara |
| 25 Aug 2026 | FTSE 250 shares round-up: Vistry rallies, Chesnara, Volex |
| 25 Aug 2026 | Chesnara CEO: 79% jump in capital generation fuels acquisition ambitions |
Lord Macpherson of Earl's Court has interests in this issuer
| 26 Aug 2026 |
| 07:00:02 |
| Director/PDMR Shareholding |
| 29 Aug 2026 |
| Chesnara, Solvonis Therapeutics, hVIVO, Gelion, Tertiary Minerals, Iofina - Small Cap Week in Review |
| 28 Aug 2026 | Insider: FTSE 250 directors lock in 7% yield |
| 27 Aug 2026 | RBC lifts Chesnara price target to 400p on stronger cash generation |
| 26 Aug 2026 | Berenberg raises target price on Chesnara |
| 25 Aug 2026 | FTSE 250 shares round-up: Vistry rallies, Chesnara, Volex |
| 25 Aug 2026 | Chesnara CEO: 79% jump in capital generation fuels acquisition ambitions |
Lord Macpherson of Earl's Court has interests in this issuer
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £23.35bn | -0.1% | |
| £16.26bn | +0.3% | |
| £9.01bn | +0.4% | |
CSNChesnara plc | £825m | +0.3% |
| £426m | +0.2% | |
| £160m | +0.1% |
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £23.35bn | -0.1% | |
| £16.26bn | +0.3% | |
| £9.01bn | +0.4% | |
CSNChesnara plc | £825m | +0.3% |
| £426m | +0.2% | |
| £160m | +0.1% |
